title: F-18 FDG uptake in a patient with psoriatic arthritis: imaging correlation with patient symptoms.
abstract: The authors describe a patient with psoriatic arthritis in whom an increased level of F-18 fluorodeoxyglucose (F-18 FDG) uptake was seen in the joints of the hands. The areas of increased activity correlated well with the regions of symptoms reported by the patient. This case illustrates the potential use of F-18 FDG positron emission tomography to quantitatively assess the degree of arthritis activity.
authors.affiliation: Division of Nuclear Medicine, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
authors.forename: M
authors.initials: M
authors.lastname: Yun
authors.forename: W
authors.initials: W
authors.lastname: Kim
authors.forename: L E
authors.initials: LE
authors.lastname: Adam
authors.forename: N
authors.initials: N
authors.lastname: Alnafisi
authors.forename: C
authors.initials: C
authors.lastname: Herman
authors.forename: A
authors.initials: A
authors.lastname: Alavi
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D015535:Arthritis, Psoriatic / Q000150:complications / Q000000981:diagnostic imaging*; D003937:Diagnosis, Differential; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy; D008875:Middle Aged; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D014055:Tomography, Emission-Computed / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18